☆ 4.3 Editorial Material

Comment on KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study

LEUKEMIA RESEARCH (2017)

Get Full Text
Add to Collection

Journal

LEUKEMIA RESEARCH
Volume 55, Issue -, Pages 55-57

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2017.01.009

Keywords

-

Categories

Oncology Hematology

Funding

  1. Beat Cancer Project/Cancer Council SA/SAHMRI Research Grant

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.